3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid

C75H96N10O20S — CID 146181374

IUPAC3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid
SMILESC=C1CC2C(O)N(C(=O)OCc3ccc(NC(=O)C(CCCCN)NC(=O)C(Cc4ccccc4)NC(=O)CCOC(C)(C)COC(C)(C)CCNC(=O)CCN4C(=O)C=CC4=O)cc3)c3cc(OCCCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)CC4C(S(=O)(=O)O)N5)c(OC)cc3C(=O)N2C1
InChIInChI=1S/C75H96N10O20S/c1-46-35-57-69(106(96,97)98)81-54-40-61(59(99-7)38-51(54)70(92)83(57)42-46)101-32-15-10-16-33-102-62-41-56-52(39-60(62)100-8)71(93)84-43-47(2)36-58(84)72(94)85(56)73(95)103-44-49-20-22-50(23-21-49)78-67(90)53(19-13-14-29-76)80-68(91)55(37-48-17-11-9-12-18-48)79-64(87)27-34-104-75(5,6)45-105-74(3,4)28-30-77-63(86)26-31-82-65(88)24-25-66(82)89/h9,11-12,17-18,20-25,38-41,53,55,57-58,69,72,81,94H,1-2,10,13-16,19,26-37,42-45,76H2,3-8H3,(H,77,86)(H,78,90)(H,79,87)(H,80,91)(H,96,97,98)
InChIKeyJWQZGCBGNWDMRK-UHFFFAOYSA-N
MW1489.71 g/mol
LogP6.07
Rot. Bonds37

About 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid

3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid (PubChem CID 146181374) has the molecular formula C75H96N10O20S and a molecular weight of 1489.71 g/mol. Its IUPAC name is 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid.

Molecular Properties

Compound Name3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid
PubChem CID146181374
Molecular FormulaC75H96N10O20S
Molecular Weight1489.71 g/mol
Exact Mass1488.65
IUPAC Name3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid
SMILESC=C1CC2C(O)N(C(=O)OCc3ccc(NC(=O)C(CCCCN)NC(=O)C(Cc4ccccc4)NC(=O)CCOC(C)(C)COC(C)(C)CCNC(=O)CCN4C(=O)C=CC4=O)cc3)c3cc(OCCCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)CC4C(S(=O)(=O)O)N5)c(OC)cc3C(=O)N2C1
InChIInChI=1S/C75H96N10O20S/c1-46-35-57-69(106(96,97)98)81-54-40-61(59(99-7)38-51(54)70(92)83(57)42-46)101-32-15-10-16-33-102-62-41-56-52(39-60(62)100-8)71(93)84-43-47(2)36-58(84)72(94)85(56)73(95)103-44-49-20-22-50(23-21-49)78-67(90)53(19-13-14-29-76)80-68(91)55(37-48-17-11-9-12-18-48)79-64(87)27-34-104-75(5,6)45-105-74(3,4)28-30-77-63(86)26-31-82-65(88)24-25-66(82)89/h9,11-12,17-18,20-25,38-41,53,55,57-58,69,72,81,94H,1-2,10,13-16,19,26-37,42-45,76H2,3-8H3,(H,77,86)(H,78,90)(H,79,87)(H,80,91)(H,96,97,98)
InChIKeyJWQZGCBGNWDMRK-UHFFFAOYSA-N
XLogP6.07
TPSA391.97 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds37
Heavy Atoms106
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001489.71
LogP ≤ 56.07
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid?
The IUPAC name of 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid (CID 146181374) is 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid.
What is the SMILES notation for 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid?
The canonical SMILES for 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid is C=C1CC2C(O)N(C(=O)OCc3ccc(NC(=O)C(CCCCN)NC(=O)C(Cc4ccccc4)NC(=O)CCOC(C)(C)COC(C)(C)CCNC(=O)CCN4C(=O)C=CC4=O)cc3)c3cc(OCCCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)CC4C(S(=O)(=O)O)N5)c(OC)cc3C(=O)N2C1.
What is the InChIKey of 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid?
The InChIKey is JWQZGCBGNWDMRK-UHFFFAOYSA-N. The full InChI is InChI=1S/C75H96N10O20S/c1-46-35-57-69(106(96,97)98)81-54-40-61(59(99-7)38-51(54)70(92)83(57)42-46)101-32-15-10-16-33-102-62-41-56-52(39-60(62)100-8)71(93)84-43-47(2)36-58(84)72(94)85(56)73(95)103-44-49-20-22-50(23-21-49)78-67(90)53(19-13-14-29-76)80-68(91)55(37-48-17-11-9-12-18-48)79-64(87)27-34-104-75(5,6)45-105-74(3,4)28-30-77-63(86)26-31-82-65(88)24-25-66(82)89/h9,11-12,17-18,20-25,38-41,53,55,57-58,69,72,81,94H,1-2,10,13-16,19,26-37,42-45,76H2,3-8H3,(H,77,86)(H,78,90)(H,79,87)(H,80,91)(H,96,97,98).
What are the key properties of 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid?
3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid has a molecular weight of 1489.71 g/mol, XLogP of 6.07, 37 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-[[5-[[4-[[6-amino-2-[[2-[3-[1-[4-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-2-methylbutan-2-yl]oxy-2-methylpropan-2-yl]oxypropanoylamino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methoxycarbonyl]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6-sulfonic acid is sourced from PubChem (CID 146181374), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).